Overview

Interscalene Block With Liposomal Bupivacaine vs. Interscalene Block With Bupivacaine and Adjuvants

Status:
Enrolling by invitation

Trial end date:
2024-11-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to determine whether the use of plain bupivacaine with common adjuvants for interscalene block (ISB) provides non-inferior analgesic results compared to the use of liposomal bupivacaine for ISB, in patients undergoing total shoulder arthroplasty.

Phase:

Phase 4

Details

Lead Sponsor:

Wake Forest University Health Sciences

Treatments:

Bupivacaine